KP-MRT-RY (Q54900383)

cell line

KPMRTRY
Kyoto Pediatrics-Malignant Rhabdoid Tumor-RY

Language	Label	Description	Also known as
English	KP-MRT-RY	cell line	KPMRTRY Kyoto Pediatrics-Malignant Rhabdoid Tumor-RY

Statements

instance of

cell line

1 reference

stated in

Cellosaurus release 44

23 January 2023

1 reference

Cellosaurus release 44

23 January 2023

Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity

1 reference

stated in

Cellosaurus release 44

retrieved

23 January 2023

Cellosaurus ID

CVCL_7051

Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression

1 reference

stated in

Cellosaurus release 44

retrieved

23 January 2023

Cellosaurus ID

CVCL_7051

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

stated in

Cellosaurus release 44

retrieved

23 January 2023

Cellosaurus ID

CVCL_7051

established from medical condition

kidney rhabdoid cancer

1 reference

stated in

Cellosaurus release 44

retrieved

23 January 2023

Cellosaurus ID

CVCL_7051

derived from organism type

1 reference

Cellosaurus release 44

retrieved

23 January 2023

Cellosaurus ID

CVCL_7051

Identifiers

Cellosaurus ID

CVCL_7051

1 reference

stated in

Cellosaurus release 44

retrieved

23 January 2023

Cellosaurus ID

CVCL_7051

KP-MRT-RY (Q54900383)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

KP-MRT-RY (Q54900383)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search